SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : ALTA NATURAL HERBS & SUPPLEMENTS LTD. (AHS-ASE)
AHS 33.02-1.3%Oct 26 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: K. Anders who wrote (5)9/18/1998 9:41:00 AM
From: KC Jones  Read Replies (1) of 66
 


HEPATICO TESTS EXPANDED AFTER POSITIVE RESULTS, TSE AND
NASD LISTINGS SOUGHT

Initial results from HEPATICO give optimism
to millions suffering from Hep-C

RICHMOND, B.C., Sept. 18 /CNW/ - Company President, Adolph Huckschlag,
reports that the Company is beginning to receive preliminary results from the
testing of its Hepatitis-C treatment, HEPATICO. ''The test results, which have
been reviewed by Dr. David Khoupenia, Alta's Medical Coordinator, are very
encouraging'' according to Huckschlag.
''Our results are generally supporting the conclusions of the 17 clinical
and pre-clinical trials done in Europe that HEPATICO is effective in
normalizing human liver function in Hepatitis-C sufferers.'' said Dr.
Khoupenia, ''We have documented substantial declines in liver enzyme counts in
as little as 45 days of treatment with HEPATICO. Some participants have seen
their Liver Function Test scores return to normal levels within 30 days. In
addition, nearly all the patients are reporting decreased fatigue and an
increased sense of well being; a sign that liver function is beginning to
return to normal.''
Commenting on the timing of the balance of the preliminary data
Huckschlag said, ''We expect the majority of our initial results to be in
within the next two weeks''.
Once Dr. David Khoupenia has had the opportunity to analyze and compare
test results the Company will announce their findings along with
English-translated copies of the 17 previous trials at a press conference to
be announced in early October of this year.
Due to overwhelming demand from Hepatitis-C sufferers from around the
world Alta's President announced that the Company will immediately expand its
HEPATICO tests beyond the current 100 participant limit. Sufferers interested
in participating should contact Greg Shafransky at 1.800.535.7502.
Participants are required to have full blood workings completed prior to
starting the treatment as well as the knowledge and support of their general
practitioner.
Following up on its commitment to shareholders, Alta has begun the
process to list for trading on the Toronto Stock Exchange and the NASDAQ
Bulletin Board. The company expects to complete these listings within the next
six to nine months.

-30-

For further information: Investment Information Contact: The Capitalists
Capital Corp., @ (800) 969-7222; Product Information Contact: Alta Natural
@ (800) 535-7502

ALTA NATURAL HERBS & SUPPLEMENTS LTD. has 13 releases in this database.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News